Risk Factors Update Summary

• Failure to establish, maintain, or protect patent protection could reduce services under patent protection.
• The company will continue to raise funds to operate as a going concern.
• Obtaining Category I CPT codes for VIVO is crucial for future success. This change might result in increased revenue.
• The certificate of incorporation designates the exclusive forum for resolving complaints, potentially affecting legal proceedings.
• Identified material weaknesses in internal controls could impact financial reporting accuracy.
• Reimbursement rates are unpredictable, impacting demand for products. This change could lead to revenue fluctuations.
• The ownership of common stock is highly concentrated, potentially affecting corporate decisions and stock price.
• Plans to expand VIVO launch require significant investment in infrastructure and sales representatives.
• Future sales and issuances of a substantial number of shares could impact the stock price.
• Delisting consequences include reduced liquidity and limited market quotations for securities.
• Joint marketing agreements may reduce revenues from product sales.
• Royalty agreements for LockeT may reduce future profits from the product.
• Dependence on information technology systems poses a risk to business operations.
• Failure to maintain effective internal controls could impact financial reporting accuracy or prevent fraud.